Our principal, Ms. Pauli Wong, was invited by HKUST to speak at their Entrepreneurship 101 Training Program on the topic of protecting start-ups through intellectual property. Her talk, titled “Patent 101 for Entrepreneurs and Start-Ups,” covered the fundamentals of IP, with a particular focus on patents. She highlighted often-overlooked aspects and shared invaluable tips to help start-up entrepreneurs avoid common pitfalls.

Pauli really enjoyed giving the talk and felt inspired by the positive feedback from the audience. She found it rewarding to share her knowledge about intellectual property and its importance for entrepreneurs. This experience has motivated her to give more presentations in the future, as she wants to reach more people and help them understand IP better.

On a side note, we want to wish the HKUST Entrepreneurship Center a happy 25th anniversary, which they are celebrating this week!




Our Past Events

Recommended Insights

Stealing Trade Secrets: How the Chinese Court Criminally Sentences Employees that Steal Trade Secrets - 2019 China’s Top 50 Representative IP Cases

11 June 2020
The theft of trade secrets has always been a deep concern of foreign companies thinking of doing business in China, whether it be sharing protocols with a manufacturing partner, providing technology details to a potential investor, or sharing results from an R&D collaboration. How can businesses ensure that employees do not steal secrets and share […]

Hong Kong Launches New Original Grant Patent System

17 December 2019
Hong Kong will be launching a new patent system on December 19, 2019 that includes key changes, most notably the introduction of an original grant patent system. This new patent system includes both the Patents (Amendment) Ordinance 2016 and the Patents (General) (Amendment) Rules 2019. Currently, there are two types of patent applications available in […]

Is it Sufficient to Claim an Antibody only by Describing its Antigen?

12 November 2018
Things may be brewing with respect to antibody inventions. Just how much description is sufficient? After losing in the Federal Circuit, Amgen has decided to ask the US Supreme Court to weigh in on a standard that could vastly influence the pharmaceutical and biotech industry. The story relates to Repatha™, an LDL-lowering drug from Amgen […]

China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)

30 April 2021
This is Part III of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021, one year to the date of Phase 1 of the US and China Economic and Trade Agreement. That agreement included specific provisions where China "shall permit pharmaceutical patent applicants to rely on supplemental […]
Top crossarrow-right